KBRA Releases 12 Things in Credit: January 2023
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases topical and timely commentary on credit markets, compiled from our weekly…
Year: 2023
Juji, Inc. Powers Auburn-Led, Five-University Study on Validating Personality Scores Inferred by an AI Chatbot
Study finds that AI-inferred personality scores predict important, real-world human performance on par or better…
Vartana Unveils All-in-One B2B Enterprise Sales Closing and Financing Platform to Change the Way Tech Companies Sell Software and Hardware
Company announces Series A round of financing led by Mayfield, 600% YoY growth and major…
Bryn Mawr Trust Announces Andrea Lawrence as Senior Vice President, Senior Wealth Advisor
WILMINGTON, Del.–(BUSINESS WIRE)–WSFS Financial Corporation (Nasdaq: WSFS), the parent company of Bryn Mawr Trust, today…
Fluree Announces Partnership with Fabric — Giving Consumers Control Over Personal Data-Sharing with Brands
Fintech startup Fabric pays consumers simply for watching ads Using Fluree technology, Fabric verifies users…
Palm Tree Continues Growth Trajectory and Announces Strategic Changes within Executive Leadership Team
LOS ANGELES–(BUSINESS WIRE)–Palm Tree LLC, the modern M&A advisor that provides integrated investment banking, strategic…
Restore Hyper Wellness Appoints Emma Nasif as Chief Compliance Officer
Fastest-growing retail wellness brand expands in-house legal counsel AUSTIN, Texas–(BUSINESS WIRE)–Restore Hyper Wellness (Restore), a…
Elements Receives $5 Million in Funding from Flyover Capital
Seed round extension will further Elements’ efforts to grow its client base and provide more…
Humacyte Publication in the Journal of Vascular Surgery – Vascular Science Reports the Human Acellular Vessel™ (HAV™) Remains Durable at Six Years in Patients with Peripheral Artery Disease
– HAVs observed to provide long-term perfusion to patients with critical limb ischemia – 3D…
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets
SOMERVILLE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (the “Company,” “Finch,”…
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-978, a Novel T-Cell Engager for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company…
Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates
– Adverse events were reported in patients who took the second, middle-of-the-night dose of immediate-release…
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
MALVERN, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium
MELBOURNE, Australia, Jan. 24, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Potential First FDA-approved Therapy for Treatment of Molluscum Contagiosum Prevalence of Over 6 Million Molluscum…
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
Pricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE…
Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s…
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…